LAXAI is a CRO and CDMO company based in Hyderabad, India. We offer various services in drug discovery from concept to commercialization. We work with global innovative biotech companies to accelerate their discovery programs. We are flexible to our customer requirements and offer services in FTE and FFS model.
Some of the services listed below:
Library design for Macrocyclic, Kinases, Proteases, Linkers of bioconjugation (anti-body, peptide drug-conjugates). Key intermediates synthesis. Multi-step synthesis and characterization of target molecules. Synthesis of patent examples and reference compounds and metabolites. Custom synthesis of Macrocyclics, reference standards & Impurity synthesis. Process development and cGMP manufacturing. Preclinical manufacturing and commercial manufacturing. R& D and Manufacturing of Intermediates & APIs.

At Laxai, we offer a range of Analytical Solutions supported by state-of-the-art facilities and efficient analytical team, it includes:
- Method development & validation
- Structural Elucidation
- Stability studies
- Physicochemical property determination (logP, logD, Solubility, pKa)
- Impurity profiling
- Instrumentation
- NMR: Bruker 400 MHz and can perform 1H, 13C, 11B, 19F, 31P and 2D NMR experiments like COSY, ROSY, Hetero COSY, HMQC, HMBC and Variable temperature experiments
- HPLC: UV, PDA & ELSD detectors (Waters) including CIS and Chiral columns
- Preparative HPLC up to 2 g per injection
- LC-MS: Single quad (Agilent), Ion Trap (Thermo)
- GC-MS: Agilent with auto sampler
- Polarimeter: Jasco P-130
- UV-VIS Spectrophotometer: UV-2450, Shimadzu
- FTIR: Prestige 21, Shimadzu
Laxai in-silico team excels in drug discovery design efforts in collaboration with medicinal chemistry, structural biology, chemical biology and DMPK teams, by conducting molecular modelling studies – pharmacophore and QSAR modelling, protein structure-based drug design, ligand-based drug design, fragment-based drug design, homology modelling, docking & scoring, chemo-informatics analysis and de novo designs.

Laxai is the place for seamless integration from target validation to candidate selection under one roof. We offer our clients a wide range of integrated drug discovery and development solutions, with core expertise founded in synthetic, medicinal and process chemistry, further augmented by preclinical services including DMPK and toxicology.
- Identification of Hit molecules (HI)
-Identification of lead molecule (LI)
- Lead optimization (LO) to Candidate Development (CD) or Pre-Clinical Candidate (PCC)